Prevalence of chlorhexidine-resistant methicillin-resistant Staphylococcus aureus following prolonged exposure

Antimicrobial Agents and Chemotherapy

Volumn 58, Issue 8, 2014, Pages 4404-4410

  Schlett, Carey D ^a   Millar, Eugene V ^a   Crawford, Katrina B ^a   Cui, Tianyuan ^a   Lanier, Jeffrey B ^b   Tribble, David R ^a   Ellis, Michael W ^a  

^a Uniformed Services University of the Health Sciences   (United States)

^b MARTIN ARMY COMMUNITY HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHLORHEXIDINE; PSEUDOMONIC ACID; TOPICAL ANTIINFECTIVE AGENT;

ADOLESCENT; ADULT; ANTIBIOTIC RESISTANCE; BACTERIAL GENE; BACTERIUM IDENTIFICATION; CONTROLLED STUDY; DRUG EFFECTS; GENETICS; GROWTH, DEVELOPMENT AND AGING; HAND WASHING; HUMAN; MALE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MICROBIAL SENSITIVITY TEST; MICROBIOLOGY; PULSED FIELD GEL ELECTROPHORESIS; RANDOMIZED CONTROLLED TRIAL; SOLDIER; STAPHYLOCOCCAL INFECTIONS;

ADOLESCENT; ADULT; ANTI-INFECTIVE AGENTS, LOCAL; BACTERIAL TYPING TECHNIQUES; CHLORHEXIDINE; DRUG RESISTANCE, BACTERIAL; ELECTROPHORESIS, GEL, PULSED-FIELD; GENES, BACTERIAL; HAND DISINFECTION; HUMANS; MALE; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; MICROBIAL SENSITIVITY TESTS; MILITARY PERSONNEL; MUPIROCIN; STAPHYLOCOCCAL INFECTIONS;

EID: 84905384458     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.02419-14     Document Type: Article

References (43)

1. Hersh AL, Chambers HF, Maselli JH, Gonzales R. 2008. National trends in ambulatory visits and antibiotic prescribing for skin and soft-tissue infections. Arch. Intern. Med. 168:1585-1591. http://dx.doi.org/10.1001/ archinte.168.14.1585.
2. Pallin DJ, Egan DJ, Pelletier AJ, Espinola JA, Hooper DC, Camargo CA, Jr. 2008. Increased US emergency department visits for skin and soft tissue infections, and changes in antibiotic choices, during the emergence of community-associated methicillin-resistant Staphylococcus aureus. Ann. Emerg. Med. 51:291-298. http://dx.doi.org/10.1016/j.annemergmed.2007.12.004.
3. Talan DA, Krishnadasan A, Gorwitz RJ, Fosheim GE, Limbago B, Albrecht V, Moran GJ, EMERGEncy ID Net Study Group. 2011. Comparison of Staphylococcus aureus from skin and soft-tissue infections in US emergency department patients, 2004 and 2008. Clin. Infect. Dis. 53:144-149. http://dx.doi.org/10.1093/cid/ cir308.
4. Klein E, Smith DL, Laxminarayan R. 2009. Community-associated methicillinresistant Staphylococcus aureus in outpatients, United States, 1999-2006. Emerg. Infect. Dis. 15:1925-1930. http://dx.doi.org/10.3201/eid1512. 081341.
5. Kazakova SV, Hageman JC, Matava M, Srinivasan A, Phelan L, Garfinkel B, Boo T, McAllister S, Anderson J, Jensen B, Dodson D, Lonsway D, McDougal LK, Arduino M, Fraser VJ, Killgore G, Tenover FC, Cody S, Jernigan DB. 2005. A clone of methicillin-resistant Staphylococcus aureus among professional football players. N. Engl. J. Med. 352:468-475. http://dx.doi.org/10.1056/NEJMoa042859.
6. Aiello AE, Lowy FD, Wright LN, Larson EL. 2006. Methicillin-resistant Staphylococcus aureus among US prisoners and military personnel: review and recommendations for future studies. Lancet Infect. Dis. 6:335-341. http://dx.doi.org/10.1016/S1473-3099(06)70491-1.
7. Army Medical Surveillance Activity. 2011. Ambulatory clinic visits among members of active components, U. S. Armed Forces, 2010. MSM. 18:16-21.
8. Salgado CD, Farr BM, Calfee DP. 2003. Community-acquired methicillinresistant Staphylococcus aureus: a meta-analysis of prevalence and risk factors. Clin. Infect. Dis. 36:131-139. http://dx.doi.org/10.1086/345436.
9. Milstone AM, Passaretti CL, Perl TM. 2008. Chlorhexidine: expanding the armamentarium for infection control and prevention. Clin. Infect. Dis. 46:274-281. http://dx.doi.org/10.1086/524736.
10. Campbell KM, Vaughn AF, Russell KL, Smith B, Jimenez DL, Barrozo CP, Minarcik JR, Crum NF, Ryan MA. 2004. Risk factors for communityassociated methicillin-resistant Staphylococcus aureus infections in an outbreak of disease among military trainees in San Diego, California, in 2002. J. Clin. Microbiol. 42:4050-4053. http://dx.doi.org/10.1128/JCM.42.9.4050-4053.2004.
11. Wootton SH, Arnold K, Hill HA, McAllister S, Ray M, Kellum M, LaMarre M, Lane ME, Chaitram J, Lance-Parker S, Kuehnert MJ. 2004. Intervention to reduce the incidence of methicillin-resistant Staphylococcus aureus skin infections in a correctional facility in Georgia. Infect. Control Hosp. Epidemiol. 25:402-407. http://dx.doi.org/10.1086/502413.
12. Miller LG, Tan J, Eells SJ, Benitez E, Radner AB. 2012. Prospective investigation of nasal mupirocin, hexachlorophene body wash, and systemic antibiotics for prevention of recurrent community-associated methicillinresistant Staphylococcus aureus infections. Antimicrob. Agents Chemother. 56:1084-1086. http://dx.doi.org/10.1128/AAC.01608-10.
13. Fritz SA, Hogan PG, Hayek G, Eisenstein KA, Rodriguez M, Epplin EK, Garbutt J, Fraser VJ. 2012. Household versus individual approaches to eradication of community-associated Staphylococcus aureus in children: a randomized trial. Clin. Infect. Dis. 54:743-751. http://dx.doi.org/10.1093/cid/ cir919.
14. Liu C, Bayer A, Cosgrove SE, Daum RS, Fridkin SK, Gorwitz RJ, Kaplan SL, Karchmer AW, Levine DP, Murray BE, Rybak MJ, Talan DA, Chambers HF. 2011. Clinical practice guidelines by the Infectious Diseases Society of America for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children. Clin. Infect. Dis. 52:e18-e55. http://dx.doi.org/10.1093/ cid/ciq146.
15. Daum RS, Spellberg B. 2012. Progress toward a Staphylococcus aureus vaccine. Clin. Infect. Dis. 54:560-567. http://dx.doi.org/10.1093/cid/cir828.
16. Whitman TJ, Herlihy RK, Schlett CD, Murray PR, Grandits GA, Ganesan A, Brown M, Mancuso JD, Adams WB, Tribble DR. 2010. Chlorhexidine-impregnated cloths to prevent skin and soft-tissue infection in Marine recruits: a cluster-randomized, double-blind, controlled effectiveness trial. Infect. Control Hosp. Epidemiol. 31:1207-1215. http://dx.doi.org/10.1086/657136.
17. Morrison SM, Blaesing CR, Millar EV, Chukwuma U, Schlett CD, Wilkins KJ, Tribble DR, Ellis MW. 2013. Evaluation of methicillinresistant Staphylococcus aureus skin and soft-tissue infection prevention strategies at a military training center. Infect. Control Hosp. Epidemiol. 34:841-843. http://dx.doi.org/10.1086/671278.
18. Batra R, Cooper BS, Whiteley C, Patel AK, Wyncoll D, Edgeworth JD. 2010. Efficacy and limitation of a chlorhexidine-based decolonization strategy in preventing transmission of methicillin-resistant Staphylococcus aureus in an intensive care unit. Clin. Infect. Dis. 50:210-217. http://dx.doi.org/10.1086/ 648717.
19. Skovgaard S, Larsen MH, Nielsen LN, Skov RL, Wong C, Westh H, Ingmer H. 2013. Recently introduced qacA/B genes in Staphylococcus epidermidis do not increase chlorhexidine MIC/MBC. J. Antimicrob. Chemother. 68:2226-2233. http://dx.doi.org/10.1093/jac/dkt182.
20. Lee AS, Macedo-Vinas M, Francois P, Renzi G, Schrenzel J, Vernaz N, Pittet D, Harbarth S. 2011. Impact of combined low-level mupirocin and genotypic chlorhexidine resistance on persistent methicillin-resistant Staphylococcus aureus carriage after decolonization therapy: a case-control study. Clin. Infect. Dis. 52:1422-1430. http://dx.doi.org/10.1093/cid/cir233.
21. McDanel JS, Murphy CR, Diekema DJ, Quan V, Kim DS, Peterson EM, Evans KD, Tan GL, Hayden MK, Huang SS. 2013. Chlorhexidine and mupirocin susceptibilities of methicillin-resistant Staphylococcus aureus from colonized nursing home residents. Antimicrob. Agents Chemother. 57:552-558. http://dx.doi.org/10.1128/ AAC.01623-12.
22. McGann P, Kwak YI, Summers A, Cummings JF, Waterman PE, Lesho EP. 2011. Detection of qacA/B in clinical isolates of methicillin-resistant Staphylococcus aureus from a regional healthcare network in the eastern United States. Infect. Control Hosp. Epidemiol. 32:1116-1119. http://dx.doi.org/10.1086/662380.
23. McGann P, Milillo M, Kwak YI, Quintero R, Waterman PE, Lesho E. 2013. Rapid and simultaneous detection of the chlorhexidine and mupirocin resistance genes qacA/B and mupA in clinical isolates of methicillinresistant Staphylococcus aureus. Diagn. Microbiol. Infect. Dis. 77:270-272. http://dx.doi.org/10.1016/j.diagmicrobio.2013.06.006.
24. Johnson MD, Schlett CD, Grandits GA, Mende K, Whitman TJ, Tribble DR, Hospenthal DR, Murray PR. 2012. Chlorhexidine does not select for resistance in Staphylococcus aureus isolates in a community setting. Infect. Control Hosp. Epidemiol. 33:1061-1063. http://dx.doi.org/10.1086/667744.
25. Fritz SA, Hogan PG, Camins BC, Ainsworth AJ, Patrick C, Martin MS, Krauss MJ, Rodriguez M, Burnham CA. 2013. Mupirocin and chlorhexidine resistance in Staphylococcus aureus in patients with community-onset skin and soft tissue infections. Antimicrob. Agents Chemother. 57:559-568. http://dx.doi.org/10.1128/ AAC.01633-12.
26. Ellis MW, Schlett CD, Millar EV, Wilkins KJ, Crawford KB, Morrison-Rodriguez SM, Pacha LA, Gorwitz RJ, Lanier JB, Tribble DR. 2014. Hygiene strategies to prevent methicillin-resistant Staphylococcus aureus skin and soft tissue infections: a cluster-randomized controlled trial among high-risk military trainees. Clin. Infect. Dis. 58:1540-1548. http://dx.doi.org/10.1093/cid/ciu166.
27. Clinical and Laboratory Standards Institute. 2007. Performance standards for antimicrobial susceptibility testing; 16th informational supplement. M100-S17. Clinical and Laboratory Standards Institute, Wayne, PA.
28. Fiebelkorn KR, Crawford SA, McElmeel ML, Jorgensen JH. 2003. Practical disk diffusion method for detection of inducible clindamycin resistance in Staphylococcus aureus and coagulase-negative staphylococci. J. Clin. Microbiol. 41:4740-4744. http://dx.doi.org/10.1128/JCM.41.10.4740-4744.2003.
29. Clinical and Laboratory Standards Institute. 2009. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. Approved standard M07-A8. Clinical and Laboratory Standards Institute, Wayne, PA.
30. Patel JB, Gorwitz RJ, Jernigan JA. 2009. Mupirocin resistance. Clin. Infect. Dis. 49:935-941. http://dx.doi.org/10.1086/605495.
31. Bannerman TL, Hancock GA, Tenover FC, Miller JM. 1995. Pulsed-field gel electrophoresis as a replacement for bacteriophage typing of Staphylococcus aureus. J. Clin. Microbiol. 33:551-555.
32. McDougal LK, Steward CD, Killgore GE, Chaitram JM, McAllister SK, Tenover FC. 2003. Pulsed-field gel electrophoresis typing of oxacillinresistant Staphylococcus aureus isolates from the United States: establishing a national database. J. Clin. Microbiol. 41:5113-5120. http://dx.doi.org/10.1128/JCM.41.11. 5113-5120.2003.
33. Miyazaki NH, Abreu AO, Marin VA, Rezende CA, Moraes MT, Villas Boas MH. 2007. The presence of qacA/B gene in Brazilian methicillinresistant Staphylococcus aureus. Mem. Inst. Oswaldo Cru. 102:539-540. http://dx.doi.org/ 10.1590/S0074-02762007000400018.
34. Vali L, Davies SE, Lai LL, Dave J, Amyes SG. 2008. Frequency of biocide resistance genes, antibiotic resistance and the effect of chlorhexidine exposure on clinical methicillin-resistant Staphylococcus aureus isolates. J. Antimicrob. Chemother. 61:524-532. http://dx.doi.org/10.1093/jac/dkm520.
35. Ho J, Branley J. 2012. Prevalence of antiseptic resistance genes qacA/B and specific sequence types of methicillin-resistant Staphylococcus aureus in the era of hand hygiene. J. Antimicrob. Chemother. 67:1549-1550. http://dx.doi.org/10.1093/jac/dks035.
36. Wang JT, Sheng WH, Wang JL, Chen D, Chen ML, Chen YC, Chang SC. 2008. Longitudinal analysis of chlorhexidine susceptibilities of nosocomial methicillin-resistant Staphylococcus aureus isolates at a teaching hospital in Taiwan. J. Antimicrob. Chemother. 62:514-517. http://dx.doi.org/10.1093/jac/ dkn208.
37. Zhang M, O'Donoghue MM, Ito T, Hiramatsu K, Boost MV. 2011. Prevalence of antiseptic-resistance genes in Staphylococcus aureus and coagulase-negative staphylococci colonising nurses and the general population in Hong Kong. J. Hosp. Infect. 78:113-117. http://dx.doi.org/10.1016/j.jhin.2011.02.018.
38. Paulsen IT, Brown MH, Littlejohn TG, Mitchell BA, Skurray RA. 1996. Multidrug resistance proteins QacA and QacB from Staphylococcus aureus: membrane topology and identification of residues involved in substrate specificity. Proc. Natl. Acad. Sci. U. S. A. 93:3630-3635. http://dx.doi.org/10.1073/pnas.93. 8.3630.
39. Paulsen IT, Skurray RA, Tam R, Saier MH, Jr, Turner RJ, Weiner JH, Goldberg EB, Grinius LL. 1996. The SMR family: a novel family of multidrug efflux proteins involved with the efflux of lipophilic drugs. Mol. Microbiol. 19:1167-1175. http://dx.doi.org/10.1111/j.1365-2958.1996.tb02462.x.
40. Horner C, Mawer D, Wilcox M. 2012. Reduced susceptibility to chlorhexidine in staphylococci: is it increasing and does it matter? J. Antimicrob. Chemother. 67:2547-2559. http://dx.doi.org/10.1093/jac/dks284.
41. Mayer S, Boos M, Beyer A, Fluit AC, Schmitz FJ. 2001. Distribution of the antiseptic resistance genes qacA, qacB and qacC in 497 methicillinresistant and-Susceptible European isolates of Staphylococcus aureus. J. Antimicrob. Chemother. 47:896-897. http://dx.doi.org/10.1093/jac/47.6.896.
42. DeMarco CE, Cushing LA, Frempong-Manso E, Seo SM, Jaravaza TA, Kaatz GW. 2007. Efflux-related resistance to norfloxacin, dyes, and biocides in bloodstream isolates of Staphylococcus aureus. Antimicrob. Agents Chemother. 51:3235-3239. http://dx.doi.org/10.1128/AAC.00430-07.
43. Alam MM, Kobayashi N, Uehara N, Watanabe N. 2003. Analysis on distribution and genomic diversity of high-level antiseptic resistance genes qacA and qacB in human clinical isolates of Staphylococcus aureus. Microb. Drug Resist. 9:109-121. http://dx.doi.org/10.1089/107662903765826697.